MSB 4.78% $1.20 mesoblast limited

LVAD

  1. 8 Posts.
    As we face a shortage of donated hearts for transplant, the study authors are calling for the devices to be considered as a tool which can allow patients to restore their health.

    The research examined the effect of mechanical heart pumps, known as left ventricular assist devices (LVAD).
    The devices are used to support patients with severe heart failure while they wait for a heart transplant.
    Surgeons implant the battery operated, mechanical pump which helps the main pumping chamber of the heart- the left ventricle - - to push blood around the body. Fitted at the six specialist NHS centres across the UK, LVADs are used for patients who have reached the end stage of heart failure.

    Publishing today in the Journal of American College of Cardiology, the team report that LVAD combined with medication can fully restore heart function in patients.

    Read more at: https://medicalxpress.com/news/2017-04-heart-failure-health-shown.html#jCp
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.20
Change
-0.060(4.78%)
Mkt cap ! $1.367B
Open High Low Value Volume
$1.22 $1.23 $1.18 $4.789M 3.988M

Buyers (Bids)

No. Vol. Price($)
13 50573 $1.20
 

Sellers (Offers)

Price($) Vol. No.
$1.20 140155 20
View Market Depth
Last trade - 12.32pm 25/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.